By Counterforce Health Team in Zokinvy (lonafarnib) —

Zokinvy (Lonafarnib) Approval with Humana in New York: Complete Coverage Guide and Appeals Process

Answer Box: Getting Zokinvy (Lonafarnib) Covered by Humana in New York

Zokinvy requires prior authorization under all Humana plans for patients with confirmed HGPS or processing-deficient progeroid laminopathies. To get coverage: (1) Obtain genetic testing confirmation via LMNA gene sequencing, (2) Have your specialist submit PA documentation including diagnosis, BSA calculation (≥0.39 m²), and monitoring plan, (3) Order through Biologics by McKesson specialty pharmacy. Medicare patients appeal through CMS, not New York State DFS. Start today by contacting the Progeria Research Foundation for free genetic testing if diagnosis is pending.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Timing and Urgency
  4. Medical Necessity Criteria
  5. Costs and Coverage Gaps
  6. Denials and Appeals
  7. Renewals and Ongoing Coverage
  8. Specialty Pharmacy Requirements
  9. Troubleshooting Common Issues
  10. Frequently Asked Questions

Coverage Basics

Is Zokinvy Covered by Humana?

Yes, Zokinvy is covered under Humana Medicare Part D and Medicare Advantage plans as of 2024-2026 formulary policies. The medication requires prior authorization across all Humana plans due to its specialty drug status and high cost (approximately $90,000 per month at typical doses).

Which Humana Plans Cover Zokinvy?

  • Medicare Advantage (Part C): Covered with pharmacy benefits
  • Medicare Part D: Standalone prescription drug plans
  • Medicaid Managed Care: Where Humana serves as the plan administrator

Note: Commercial employer plans may have different formulary structures—verify coverage directly with your plan administrator.

Coverage at a Glance

Requirement Details Where to Find It
Prior Authorization Required for all plans Humana Pharmacy Policies
Age Requirement ≥12 months FDA Label
BSA Requirement ≥0.39 m² FDA Label
Quantity Limit 360 capsules per 90 days Humana Policy
Specialty Pharmacy Biologics by McKesson only McKesson Announcement

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Confirm Diagnosis (Patient/Family)
    • Contact Progeria Research Foundation for free LMNA gene testing
    • Timeline: 2-4 weeks for results
    • Required: Clinical photos, growth charts, family history
  2. Gather Clinical Documentation (Healthcare Provider)
    • BSA calculation confirming ≥0.39 m²
    • Confirmed HGPS or processing-deficient progeroid laminopathy diagnosis
    • Baseline labs (CBC, LFTs, electrolytes, renal function)
    • Timeline: 1-2 business days
  3. Submit Prior Authorization (Healthcare Provider)
    • Submit via Humana provider portal or call 877-486-2621
    • Include genetic test results, clinical notes, monitoring plan
    • Timeline: 5-15 business days for standard review
  4. Coordinate Specialty Pharmacy (Healthcare Provider/Patient)
    • Prescription sent to Biologics by McKesson
    • Contact Sentynl Cares at 1-888-251-2800 for support
    • Timeline: 2-3 business days for first shipment

Clinician Corner: Medical Necessity Letter Checklist

Your medical necessity letter should include:

  • Confirmed diagnosis: HGPS or processing-deficient progeroid laminopathy with genetic testing results
  • Patient eligibility: Age ≥12 months, BSA ≥0.39 m², weight-based dosing plan
  • Clinical rationale: Life-threatening nature of condition, FDA approval for mortality risk reduction
  • Monitoring plan: Agreement to monitor electrolytes, CBC, LFTs, renal function, ophthalmological evaluations
  • Contraception counseling: For females of reproductive potential (per FDA requirements)

Timing and Urgency

Standard Review Timeline

  • Humana standard PA review: 5-15 business days
  • Expedited review: 48-72 hours (requires urgent medical need documentation)
  • Appeal timeline: 30 days for Medicare Advantage, 7 days for Part D

When to Request Expedited Review

Request expedited review if:

  • Patient has rapid disease progression
  • Delay would pose serious health risks
  • Current supportive care is insufficient
Tip: Document specific clinical deterioration (growth velocity, cardiovascular changes, bone density loss) to support expedited requests.

Medical Necessity Criteria

FDA-Approved Indications

Zokinvy is approved for patients 12 months and older with BSA ≥0.39 m² for:

  1. Hutchinson-Gilford Progeria Syndrome (HGPS): Reducing mortality risk
  2. Processing-deficient Progeroid Laminopathies with either:
    • Heterozygous LMNA mutation with progerin-like protein accumulation
    • Homozygous or compound heterozygous ZMPSTE24 mutations

Required Documentation

  • Genetic confirmation: LMNA gene sequencing results
  • Age verification: Birth certificate or medical records
  • BSA calculation: Height and weight measurements with calculated BSA
  • Baseline monitoring: Labs confirming safe starting parameters
  • Specialist oversight: Genetics, pediatrics, or other relevant specialist involvement

Common Denial Reasons & Solutions

Denial Reason How to Address
Missing genetic testing Submit LMNA gene sequencing results from certified lab
Insufficient BSA documentation Provide recent height/weight with BSA calculation
Lack of specialist involvement Include referral to genetics or pediatric specialist
Inadequate monitoring plan Detail lab schedule and ophthalmological evaluations
Off-label dosing request Ensure dosing aligns with FDA label recommendations

Costs and Coverage Gaps

Medicare Coverage Structure (2024-2026)

Under Humana Medicare Part D:

  • Deductible phase: Patient pays full cost until deductible met
  • Initial coverage: Copay/coinsurance until $2,100 out-of-pocket
  • Catastrophic coverage: Plan pays 100% after $2,100 annual cap

Patient Assistance Options

  1. Zokinvy CONNECT Program
    • Call 833-235-3369 for manufacturer support
    • Copay assistance up to $15,000/year (income-based)
    • Medicare patients may qualify if not government-insured only
  2. Medicare Prescription Payment Plan
    • Spread out-of-pocket costs monthly
    • No additional fees, voluntary enrollment
    • Contact Humana to enroll
  3. Extra Help Program
    • Low-income Medicare subsidy
    • Up to $5,300/year in additional coverage
    • Apply at ssa.gov

Denials and Appeals

Appeal Process for Medicare Patients

Important: Medicare patients cannot use New York State's external appeal process. Appeals must go through federal Medicare procedures.

Internal Appeals (First Level)

  1. Timeline: File within 60 days of denial
  2. How to file: Call Humana at 1-800-833-6917 or submit via member portal
  3. Decision timeline: 30 days (Part C), 7 days (Part D)
  4. Expedited option: 72 hours if urgent

External Review (Second Level)

  1. Who handles it: Independent Review Entity (IRE) contracted by CMS
  2. Timeline: File within 60 days of internal appeal denial
  3. Cost: Free to Medicare beneficiaries
  4. Decision timeline: 30 days standard, 72 hours expedited

Appeals Playbook: Required Documentation

  • Original denial letter with specific reason codes
  • Updated medical necessity letter addressing denial reasons
  • Additional clinical documentation (labs, imaging, specialist notes)
  • Peer-reviewed literature supporting treatment (if applicable)
  • Patient impact statement describing disease progression
From our advocates: "We've seen Zokinvy appeals succeed when families include detailed documentation of disease progression—growth charts, photos showing physical changes, and specialist letters explaining the urgency. The key is addressing each specific denial reason with clinical evidence."

Renewals and Ongoing Coverage

Annual Reauthorization Requirements

  • Timeline: Submit 30-60 days before expiration
  • Required documentation: Updated labs, continued medical necessity, treatment response
  • Approval duration: Typically 12 months
  • Monitoring compliance: Document completion of required safety monitoring

What Changes May Trigger Review

  • Dosing adjustments outside FDA parameters
  • Change in prescribing physician
  • Switch between Humana plan types
  • New safety concerns or contraindications

Specialty Pharmacy Requirements

Why Biologics by McKesson?

Biologics by McKesson is the exclusive U.S. specialty pharmacy for Zokinvy distribution, selected by manufacturer Sentynl Therapeutics in September 2024.

Coordination Process

  1. Provider responsibilities: Send prescription to Biologics by McKesson
  2. Patient support: Contact Sentynl Cares at 1-888-251-2800
  3. Shipping: Specialized handling for oral capsules
  4. Monitoring: Coordinate refills with ongoing lab requirements

Troubleshooting Common Issues

Portal and System Problems

  • Humana provider portal down: Call 877-486-2621 for phone submission
  • Missing PA forms: Download from Humana provider resources
  • Specialty pharmacy delays: Contact Sentynl Cares for status updates

Documentation Issues

  • Genetic testing delays: PRF offers expedited processing for urgent cases
  • BSA calculation questions: Use standard pediatric formulas (√[height(cm) × weight(kg)]/3600)
  • Monitoring compliance: Establish clear lab schedule with primary care coordination

Frequently Asked Questions

How long does Humana prior authorization take for Zokinvy in New York? Standard review takes 5-15 business days. Expedited review (for urgent cases) takes 48-72 hours. Timeline starts when complete documentation is received.

What if Zokinvy is non-formulary on my Humana plan? Submit a formulary exception request with medical necessity documentation. Include evidence that formulary alternatives are inappropriate for progeria treatment.

Can I request an expedited appeal if Humana denies coverage? Yes, if delay would seriously jeopardize your health. Provide clinical documentation of disease progression and urgency for expedited 72-hour review.

Does step therapy apply to Zokinvy coverage? Step therapy typically doesn't apply since Zokinvy is the only FDA-approved treatment for HGPS. However, plans may require documentation that supportive care alone is insufficient.

What happens if I move from New York to another state? Humana Medicare coverage follows you nationwide. Notify Humana of address changes to ensure continued specialty pharmacy coordination.

Are there alternatives if Humana continues to deny coverage? Consider switching to a different Medicare Part D plan during open enrollment, explore clinical trials, or contact patient advocacy organizations for additional support resources.

When to Escalate Beyond Humana

If internal and external Medicare appeals are unsuccessful:

  • Contact Medicare directly: 1-800-MEDICARE for coverage complaints
  • CMS Regional Office: File complaints about plan compliance
  • Congressional representatives: Assistance with federal program issues
  • Patient advocacy groups: National Organization for Rare Disorders (NORD)

Counterforce Health specializes in turning insurance denials into successful appeals by creating targeted, evidence-backed rebuttals that address each denial reason with the right clinical documentation and peer-reviewed citations. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeal processes for specialty medications like Zokinvy.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal procedures may change. Always verify current requirements with Humana and consult your healthcare provider for medical decisions. For personalized assistance with insurance appeals and prior authorizations, consider consulting with coverage specialists at Counterforce Health.

Last updated: January 2025

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.